BioStock: WntResearch recruits first patient in restart of NeoFox

After receiving the green light for its redesigned study plan for NeoFox this summer, WntResearch have announced the recruitment of the first patient. The revised study is now officially underway with the first part expected to take about six months to complete. BioStock contacted CEO Pernilla Sandwall for a comment on this milestone.

Read the article at biostock.se:

https://www.biostock.se/en/2023/10/wntresearch-rekryterar-forsta-patienten-i-aterstarten-av-neofox/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/